Cargando…

The Economics of Reproducibility in Preclinical Research

Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the cumulative (total) prevalence of irreproducible preclinical research exceeds 50%, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Leonard P., Cockburn, Iain M., Simcoe, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461318/
https://www.ncbi.nlm.nih.gov/pubmed/26057340
http://dx.doi.org/10.1371/journal.pbio.1002165